GSH has been previously shown to have direct antimycobacterial effects [[85], [86], [87]] likely due to reductive stress experienced by the microbes
A common thread among new treatments is the activation of energy- sensing pathways, especially AMP- activated protein kinase (AMPK), which helps the liver break down fatty acids, stops lipogenesis and reduces inflammation and fibrosis
It may help with weight loss by reducing hunger, helping patients feel fuller for longer, and making it easier to manage portion sizes
Its also important to understand their criteria for appropriate use, including clinical criteria beyond just BMI, and the percentage of eligible patients who get approved for a GLP-1 prescription
These findings suggest that allergen-induced inflammation may result in systemic production of these pro-inflammatory cytokines, potentially increasing the risk for depression [1]